Blood and Lymphatic Diseases
1 clinical trials · Condition
◉ Watch Blood and Lymphatic Diseases
| Record | Firm | Date |
|---|---|---|
| Long - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously Exposed to BIVV003 or ST-400. (NCT05145062) | Sangamo Therapeutics | 2021-12-21 |
Track Blood and Lymphatic Diseases automatically
Every clearance here is in the API, with alerts when new ones post.